LG Innotek Co EBITDA per Employee
EBITDA per Employee of LG Innotek Co (011070.KS) as of Aug 3, 2026.
Get this data via API
Financial Data API
EBITDA per Employee
0.00KRW
Last updated:
EBITDA per Employee of LG Innotek Co is 2026 0.00 KRW. EBITDA per Employee of LG Innotek Co was 2025 0.00 KRW. It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API
LG Innotek Co Stock analysis
What does LG Innotek Co do? LG Innotek Co Ltd is a South Korean company that was founded in 1970. It is a subsidiary of the LG Group, which operates in various business sectors.
LG Innotek's business model includes the development and manufacturing of components and solutions for various industries such as automotive, electronics, lighting, and healthcare.
The company has different divisions that specialize in development and manufacturing. The automotive components division offers products such as vehicle sensors and telematics modules. The electronics components division manufactures printed circuit boards, modules, and semiconductor devices. The lighting division provides LED modules, luminaires, and light-emitting diodes. The healthcare division develops products such as blood pressure monitors and LED therapy devices.
LG Innotek has gained worldwide attention in recent years due to its innovative products and growth in the automotive and electronics markets. The company has a strong commitment to research and development and strives to develop solutions that meet the needs of its customers.
An example of this is the development of LED lighting technologies that are more energy-efficient and durable than traditional lighting systems. LG Innotek has also played an important role in the automotive industry by developing components for advanced driver assistance systems and telematics modules.
Among the products offered by LG Innotek are state-of-the-art LED modules that are used in various applications such as screen backlighting, full-color displays, street lighting, and interior lighting. The company also manufactures high-performance luminaires that can be used in various scenarios such as indoor and outdoor lighting, street lighting, and specialty lighting.
Furthermore, LG Innotek has also developed products based on LED technology in the healthcare industry. One of these developments is the LED therapy device, which is used for the treatment of various skin conditions such as acne and wrinkles. The company has also developed blood pressure monitors that enable precise and reliable measurement.
Overall, LG Innotek has established itself as a leading provider of innovative components and solutions for various industries. The company is committed to excellent quality and innovation and aims to maximize value for its customers. LG Innotek Co is one of the most popular companies on Eulerpool.
Frequently Asked Questions about LG Innotek Co stock
On Eulerpool you can find the complete historical development of EBITDA per Employee LG Innotek Co since 2006 – with annual values, charts, and detailed analysis.
EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.
EBITDA per Employee's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's LG Innotek Co historically and in real time.
Access this data via the Eulerpool API
Workforce — LG Innotek Co
All Key Metrics — LG Innotek Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth